Common Contracts

AMENDMENT NO. 2 TO SECURED CONVERTIBLE PROMISSORY NOTE

Secured Convertible Promissory Note • February 29th, 2024 • Abvc Biopharma, Inc. • Pharmaceutical preparations

• Contract Type
  Secured Convertible Promissory Note
• Filed
  February 29th, 2024
• Company
  Abvc Biopharma, Inc.
• Industry
  Pharmaceutical preparations

This Amendment No. 2 to Senior Convertible Promissory Note (this “Amendment”) is entered into as of February [ ], 2024 (the “Amendment Date”), by and between Lind Global fund II LP, a Delaware limited partnership (“Holder”), and ABVC BioPharma, Inc., a Nevada corporation (“Maker”). Capitalized terms used in this Amendment without definition shall have the meanings given to them in the Note (as defined below).

AMENDMENT NO. 1 TO SECURED CONVERTIBLE PROMISSORY NOTE

Secured Convertible Promissory Note • February 29th, 2024 • Abvc Biopharma, Inc. • Pharmaceutical preparations

• Contract Type
  Secured Convertible Promissory Note
• Filed
  February 29th, 2024
• Company
  Abvc Biopharma, Inc.
• Industry
  Pharmaceutical preparations

This Amendment No. 1 to Senior Convertible Promissory Note (this “Amendment”) is entered into as of February [ ], 2024 (the “Amendment Date”), by and between Lind Global fund II LP, a Delaware limited partnership (“Holder”), and ABVC BioPharma, Inc., a Nevada corporation (“Maker”). Capitalized terms used in this Amendment without definition shall have the meanings given to them in the Note (as defined below).